Ginkgo Allergy: Male Trees Cause Pollen, Female Trees Cause the Rash
Ginkgo biloba allergy presents 2 distinct reactions by tree sex: male trees produce wind-pollinated pollen (March–April) that can trigger mild IgE-mediated respiratory symptoms, while female trees produce seeds whose decaying sarcotesta releases ginkgolic acids — potent contact sensitizers structurally related to poison ivy's urushiol. Pollen allergy responds to seasonal antihistamines; contact allergy requires strict avoidance.
Free · 5 min · Insurance accepted
Key facts
Ginkgolic acids in female seed sarcotesta are anacardic acid derivatives sharing structural chemistry with urushiol from poison ivy — ivy-sensitized patients may develop cross-reactive contact dermatitis from ginkgo seeds.
EU standards require ginkgolic acid content below 5 ppm in dietary supplements to minimize contact sensitization risk from orally consumed Ginkgo biloba leaf extract.
4-O-methylpyridoxine in ginkgo seeds can cause seizures and vomiting in children — a pharmacological toxicity entirely separate from the allergic ginkgolic acid mechanism.
Ginkgo pollen grains are approximately 25–35 micrometers — large enough to settle rapidly near the source tree — limiting airborne dispersal and reducing the clinical significance of ginkgo as an aeroallergen.
What Is Ginkgo Allergy?
Ginkgo biloba (Ginkgoaceae) is a living fossil — the sole surviving species of an ancient plant lineage — and it presents allergists with an unusual dual-mechanism clinical picture depending on whether exposure is to pollen from male trees or to the fruit sarcotesta of female trees.
Ginkgo is dioecious, meaning male and female reproductive structures are on entirely separate trees. Only male trees produce pollen; only female trees produce seeds enclosed in a fleshy outer coat (sarcotesta) that releases butyric acid and hexanoic acid upon decay — the infamous 'ginkgo smell' often compared to vomit or rancid butter. This biology creates two clinically distinct reactions.
First: pollen allergy from male trees, an IgE-mediated Type I hypersensitivity occurring during the March to April pollen season. Ginkgo pollen is a minor aeroallergen — some IgE reactivity has been documented in urban populations, but no WHO/IUIS allergens have been characterized, and population sensitization rates are low. Second: contact dermatitis from ginkgolic acids in the female fruit's sarcotesta — a potent Type IV delayed hypersensitivity caused by anacardic acid derivatives (15:1 and 17:1 ginkgolic acids) structurally related to urushiol from poison ivy.
Municipalities have historically planted only male trees to avoid the malodorous fruit — paradoxically increasing urban pollen load while eliminating the smell and fruit contact hazard.
Symptoms of Ginkgo Allergy
Recognizing symptoms early helps you get the right treatment faster.
Seasonal rhinitis (pollen)
mildSneezing, runny nose, and nasal congestion occurring March through April from male ginkgo tree pollen inhalation.
Allergic conjunctivitis (pollen)
mildItchy, watery, and red eyes during ginkgo pollen season — typically mild compared to birch or grass pollen reactions.
Contact dermatitis rash (ginkgolic acids)
moderatePapular and vesicular rash developing 24 to 48 hours after skin contact with female ginkgo seed sarcotesta; resembles poison ivy eruption.
Hand dermatitis
moderateThe most common site for ginkgolic acid contact dermatitis, occurring in those who handle fallen seeds or cook with ginkgo nuts.
Facial eczema from cross-contamination
moderateSeeds touched and then hands contacting the face can transfer ginkgolic acid and produce perioral or eyelid dermatitis.
Throat irritation
mildMild throat pruritus or irritation may accompany seasonal pollen exposure in sensitized individuals during spring.
Ginkgo toxicity (non-immune)
severe4-O-methylpyridoxine in ginkgo seeds can cause seizures and nausea in children — this is a pharmacological toxicity, not an allergic reaction. Seek emergency care immediately if seed ingestion is followed by neurological symptoms.
When to see a doctor
Ginkgo allergy symptoms depend on which exposure pathway is involved. Pollen-related symptoms (from male trees, spring) resemble mild seasonal allergic rhinitis: sneezing, itchy and watery eyes, nasal congestion, and mild throat irritation during March and April. Because ginkgo is a minor aeroallergen with low WHO/IUIS characterization, the severity of pollen symptoms is typically mild and may be overshadowed by concurrent birch or maple pollen exposure in the same season. Contact allergy symptoms (from ginkgolic acids in female tree sarcotesta) present as a poison-ivy-like eruption: papular and vesicular rash on the hands, arms, and any body area that touched the seed's fleshy coat, developing within 24 to 48 hours of contact and intensifying over 2 to 3 days. The distribution often involves the hands and face if seeds were handled and then the face was touched. Cross-reactive patients with poison ivy sensitization may experience a more severe and rapid response. Patients consuming ginkgo nuts in cooking should be aware that raw seed handling carries dermatitis risk. A board-certified allergist can help determine which mechanism — pollen IgE or ginkgolic acid contact — is responsible for your specific symptoms. Seek immediate medical care if a severe systemic reaction occurs after ginkgo ingestion.
Ginkgo Pollen and Asthma
Ginkgo pollen's role in asthma exacerbation is not well established due to the limited characterization of ginkgo pollen allergens and the minor-aeroallergen classification of the pollen itself. In patients with pre-existing pollen-triggered asthma, any exposure to co-occurring spring tree pollens (birch, maple) during March and April could exacerbate bronchial reactivity, and ginkgo pollen may contribute in areas of high male tree density. There are no published studies directly linking ginkgo pollen exposure to asthma hospitalization or exacerbation rates. Ginkgolic acid contact dermatitis, being a Type IV skin reaction, has no established bronchial component. Patients with asthma who take ginkgo biloba leaf supplements should discuss this with their physician, as supplements have been associated with rare platelet-altering effects that could interact with certain asthma medications.
Complications of Ginkgo Allergy
The most significant complication of ginkgo allergy relates to the contact dermatitis pathway rather than pollen exposure. Severe ginkgolic acid contact dermatitis — especially in patients cross-sensitized to poison ivy — can produce extensive vesicular eruptions requiring systemic corticosteroid treatment. Without prompt recognition and avoidance, repeated exposure during autumn leaf-fall season in cities with female trees can cause progressive sensitization. A specific risk exists with ginkgo supplement use: patients who develop ginkgolic acid sensitization from fruit contact may subsequently react to dietary supplements containing inadequately purified ginkgo extract, resulting in systemic dermatitis or mucosal reactions. Ginkgo seed toxicity is a non-immune complication particularly relevant for children: 4-O-methylpyridoxine in seeds can cause seizures and vomiting at doses of more than 5 seeds in children. This is a pharmacological, not allergic, emergency requiring immediate medical attention.
Severe vesicular contact dermatitis
Extensive blistering rash similar to severe poison ivy exposure can develop, particularly in patients cross-sensitized to urushiol.
Supplement cross-reactivity
Patients sensitized to ginkgolic acids via fruit contact may react to poorly standardized ginkgo biloba supplements containing elevated ginkgolic acid concentrations.
Secondary bacterial infection
Broken vesicular lesions from contact dermatitis can become colonized by Staphylococcus aureus, requiring antibiotic treatment.
Ginkgo seed neurotoxicity (children)
4-O-methylpyridoxine in raw seeds causes vomiting and seizures in children — a medical emergency requiring immediate evaluation, distinct from allergy.
What Causes Ginkgo Allergy Reactions?
Two entirely separate exposure pathways cause ginkgo allergy. For pollen allergy, inhalation of windborne pollen from male ginkgo trees during March and April is the triggering event.
Male ginkgo — produces pollen only; no fruit
Ginkgo biloba (male)
Female ginkgo — produces seeds with allergenic sarcotesta; no pollen
Ginkgo biloba (female)
How it works
Ginkgo pollen allergy operates through Type I IgE-mediated hypersensitivity: pollen proteins bind to IgE antibodies on mast cells in sensitized individuals, triggering histamine release and the classic allergic rhinitis cascade. Ginkgolic acid contact allergy operates through Type IV delayed hypersensitivity: anacardic acid derivatives form covalent bonds with epidermal proteins via electrophilic attack, creating hapten-protein conjugates that sensitize T lymphocytes. On re-exposure, activated memory T cells release cytokines causing inflammatory dermatitis at 24 to 96 hours. Cross-reactivity with urushiol (poison ivy) occurs because ginkgolic acids and urushiol share structural features — specifically long alkyl chain substitution on a phenolic ring — allowing sensitized T-cell clones to recognize both molecules.
Ginkgo is wind-pollinated, and in cities where municipal planting policies favor male trees, localized pollen concentrations can be moderate during the brief spring pollen window. Despite documented SPT positivity in some urban populations, ginkgo pollen has not yielded characterized WHO/IUIS allergen proteins, placing it in the minor-aeroallergen category with sparse clinical data.
For ginkgolic acid contact allergy, direct skin contact with the sarcotesta of female tree seeds — the fleshy yellow-orange outer coating — is the mechanism. The ginkgolic acids (anacardic acid class, 15-carbon and 17-carbon chain variants) are among the most potent plant contact sensitizers known, and they share structural chemistry with urushiol from poison ivy and Toxicodendron oak.
Patients sensitized to poison ivy may show cross-reactivity to ginkgolic acids. Additional exposure routes include roasting ginkgo nuts for culinary use (the high-temperature process reduces but does not eliminate ginkgolic acid risk during handling), and consumption of ginkgo biloba leaf extract supplements — EU regulations require ginkgolic acid content below 5 ppm in supplements to minimize sensitization risk.
Risk factors to watch for
Proximity to female ginkgo trees
Handling or walking near fallen female ginkgo seeds in autumn significantly increases ginkgolic acid skin exposure and risk of contact sensitization.
Poison ivy cross-sensitization
Patients already sensitized to poison ivy urushiol carry cross-reactive T-cell memory that may recognize ginkgolic acids, producing contact dermatitis on first ginkgo seed contact.
Urban tree proximity (male trees)
In cities where municipal planting policies favor male trees, localized spring pollen concentrations can trigger mild respiratory symptoms in atopic individuals.
Ginkgo supplement use
Dietary supplements containing ginkgo biloba leaf extract may expose consumers to trace ginkgolic acids; EU standards require <5 ppm, but product quality varies internationally.
Culinary exposure (ginkgo nut roasting)
Handling raw ginkgo nuts during cooking — before sufficient heat has been applied — carries ginkgolic acid contact risk, particularly in Asian culinary traditions where ginkgo seeds are a common ingredient.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Is Ginkgo Allergy Diagnosed?
Diagnosing ginkgo allergy requires distinguishing between the pollen IgE mechanism and the ginkgolic acid contact mechanism, as testing approaches differ substantially. For pollen allergy, skin prick testing with ginkgo pollen extract may be performed; some SPT positivity has been documented in urban populations, but because no characterized allergen proteins are commercially standardized, extract quality varies. Specific IgE blood testing for ginkgo pollen is available through some laboratory panels. For ginkgolic acid contact allergy, patch testing is the definitive diagnostic tool. The patch test typically uses ginkgo leaf or fruit extract applied under an occlusive patch for 48 hours, with readings at 48 and 96 hours. Ginkgo is not part of the standard North American patch test series, so it requires supplemental testing with plant material or commercially prepared extract. A thorough exposure history — covering proximity to female ginkgo trees, ginkgo supplement use, and culinary ginkgo nut handling — is essential before testing. For patients who also want to evaluate IgE-mediated spring tree pollen sensitization beyond ginkgo, at-home allergy testing services such as Curex offer an alternative to in-clinic testing, with panels covering 40+ common allergens including tree pollens and results typically within 5 days — often with insurance coverage.
Skin Prick Test (Pollen)
A lancet introduces a small amount of ginkgo pollen extract into the superficial skin, and wheal formation is read at 15 minutes. Detects IgE-mediated pollen sensitization.
Specific IgE Blood Test
A blood sample is tested for IgE antibodies specific to ginkgo pollen. Detects sensitization without skin exposure and is useful for patients who cannot undergo skin testing.
Patch Testing (Ginkgolic Acids)
Ginkgo leaf or fruit extract is applied under an occlusive patch for 48 hours to detect Type IV delayed contact hypersensitivity to ginkgolic acids. Readings at 48 and 96 hours.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Patients who test positive for IgE-mediated ginkgo pollen allergy and experience disabling spring symptoms may be candidates for immunotherapy — specifically targeting the broader spring tree pollen spectrum of which ginkgo is a part. Because ginkgo pollen allergens have not been formally characterized or standardized commercially, immunotherapy extracts would focus on cross-reactive spring tree pollen proteins rather than a ginkgo-specific formulation. The spring pollen season (March to April) when ginkgo releases pollen overlaps with birch, maple, and alder seasons — meaning a patient sensitized to ginkgo pollen is likely co-sensitized to other spring tree pollens, and a multi-allergen tree pollen immunotherapy program addresses the full seasonal burden. Subcutaneous immunotherapy (allergy shots) requires weekly clinic visits for the buildup phase, which some patients find difficult to maintain. Sublingual immunotherapy drops, offered by providers like Curex starting at $39/month, can be taken at home, eliminating the need for weekly office visits while providing clinically documented desensitization for spring tree pollen sensitization. It is important to note that immunotherapy addresses only the IgE-mediated pollen pathway — the ginkgolic acid contact allergy from female tree fruit is a Type IV T-cell-mediated mechanism that is not amenable to IgE immunotherapy. Avoidance remains the only management strategy for the contact component.
Allergy Testing
Skin prick or specific IgE blood testing confirms spring tree pollen sensitization including any ginkgo pollen component.
Determine Mechanism
Establish whether your symptoms are from pollen IgE (spring respiratory) or ginkgolic acid contact (autumn skin) — they require different management.
Begin Immunotherapy (if indicated)
For IgE-confirmed spring tree pollen allergy, start sublingual drops or allergy shots targeting the full spring tree pollen panel.
Monitor and Adjust
Reassess symptoms each spring season; immunotherapy benefit accumulates progressively over 3 to 5 years of consistent treatment.
“Clinical trials of spring tree pollen SLIT/SCIT show 60–85% symptom reduction in the majority of treated patients over a full treatment course”
Treat your Ginkgo allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Ginkgo Allergy
Living with ginkgo allergy involves navigating two separate allergen calendars: the spring pollen season from male trees (March to April) and the autumn seed-fall season from female trees (August to November in most US cities). Many people are surprised to learn that a single tree species causes such mechanistically different reactions at different times of year. The good news is that both pathways are manageable once identified. Most US city-planted ginkgo trees are male (planted specifically to avoid malodorous fruit), meaning autumn contact hazard is lower in urban areas — though not eliminated in cities with older mixed or female plantings. Identifying the ginkgo trees in your immediate environment — whether they produce seeds in autumn — can substantially clarify your personal risk. For supplement users, the key concern is ensuring adequate standardization of purchased ginkgo products to minimize hidden ginkgolic acid exposure year-round.
Know your local trees
Identify whether ginkgo trees in your neighborhood, campus, or workplace are male (no fruit) or female (produce fleshy seeds in autumn). Female trees with visible seed fall represent your primary autumn contact hazard.
Spring pollen routine
During the March to April window, take your antihistamine or nasal spray proactively rather than reactively. Starting intranasal corticosteroids one week before typical symptom onset can prevent the initial inflammatory response.
Inform your kitchen
If ginkgo nuts appear in recipes you prepare or meals served at Asian restaurants, be aware of your personal sensitization level. Well-cooked seeds are lower risk; raw handling requires gloves if you have confirmed ginkgolic acid contact allergy.
Seasonal Patterns
March - April
low intensity
August - November
medium intensity
Prevention Tips
Track spring pollen counts
During March and April, check local pollen forecasts and reduce outdoor activity on high tree pollen count days to minimize ginkgo pollen inhalation.
Wear gloves near female trees
In autumn when ginkgo seeds fall and decay, wear disposable gloves when walking through areas with female ginkgo trees, especially if picking up or handling seeds.
Immediate skin washing
If skin contacts ginkgo seed sarcotesta, wash the exposed area with soap and water within 10 minutes to reduce ginkgolic acid absorption before sensitization occurs.
Verify supplement purity
If taking ginkgo biloba supplements, choose products specifying ginkgolic acid content below 5 ppm — the standard used in the EU — to minimize contact sensitization risk from ingested extracts.
Identify tree sex before handling
Learn to identify female trees (those producing nuts or seeds in autumn) in your neighborhood or workplace vicinity so you can be alert during seed-fall season.
Prognosis for Ginkgo Allergy
The prognosis for ginkgo allergy depends on which mechanism is responsible for symptoms. Pollen allergy (spring, IgE-mediated) is a manageable chronic condition: symptoms can be well controlled with antihistamines and nasal sprays during the brief March to April season, and immunotherapy targeting the spring tree pollen panel can provide sustained long-term benefit. Because ginkgo is a minor aeroallergen with relatively short pollen season, pollen symptoms alone are typically less disabling than major allergen exposures. Ginkgolic acid contact allergy has an excellent prognosis with avoidance: once the female tree seed contact or supplement exposure is identified and eliminated, contact dermatitis resolves and does not recur as long as re-exposure is prevented. Contact sensitization persists immunologically — the memory T cells remain — so any future contact with ginkgolic acids will again trigger dermatitis. Patients who identify and address the correct mechanism early enjoy the best outcomes.
Key takeaways
Ginkgo pollen allergy (spring) is mild and manageable with standard seasonal antihistamines and nasal sprays
Ginkgolic acid contact allergy (autumn) resolves with avoidance and has an excellent prognosis once the exposure source is identified
Cross-sensitization with poison ivy urushiol means more severe contact reactions are possible in previously poison-ivy-sensitized patients
Ginkgo biloba supplements should be standardized to <5 ppm ginkgolic acid content for sensitized individuals
Ginkgo and Diet — The Nut Cooking Consideration
Ginkgo seeds (nuts) are used in Chinese, Japanese, and Korean cuisine, appearing in congee, stir-fries, and traditional preparations. Raw ginkgo nuts contain ginkgolic acids in significant concentrations — cooking at high temperatures reduces but does not completely eliminate these compounds during the roasting or boiling process. For patients sensitized to ginkgolic acids from skin contact, culinary exposure to inadequately cooked ginkgo nuts represents a potential risk for mucosal or systemic reactions. Traditional advice is to thoroughly cook ginkgo nuts and to limit consumption to a small number (typically no more than 10 per sitting) given the 4-O-methylpyridoxine content. Patients who have had skin reactions to female ginkgo seed sarcotesta should discuss with their allergist whether culinary ginkgo nut exposure is safe. There is no pollen-food syndrome (OAS) documented for ginkgo because the pollen allergens are not characterized and no Bet v 1 homolog or LTP has been identified in ginkgo pollen.
Foods to limit
Raw ginkgo nuts (seeds)
Raw ginkgo seeds contain ginkgolic acids and 4-O-methylpyridoxine; handling or eating raw seeds carries contact sensitization and neurotoxicity risk, especially for children.
Ginkgo teaches an important lesson about sex-dependent allergen biology — the same species causes two mechanistically opposite allergy syndromes depending on which tree sex you're near. Male trees produce pollen that follows a standard IgE pathway; female trees produce seeds whose chemistry is essentially liquid poison ivy.
Frequently Asked Questions
Ginkgo trees can cause mild hay fever-like symptoms, but only from male trees and only during the brief March to April pollen season. Ginkgo is a minor aeroallergen — its pollen has not yielded WHO/IUIS-characterized allergen proteins, and population-level sensitization rates are much lower than those for major spring tree pollens like birch or oak. In cities where municipal planners have planted predominantly male trees to avoid the malodorous female fruit, pollen exposure is concentrated but still at minor-allergen levels. If you have spring tree pollen hay fever, ginkgo may be a contributing trigger, but it is rarely the sole cause.
The notorious 'ginkgo smell' — often compared to vomit, rancid butter, or dog feces — is produced by the decaying fleshy outer coat (sarcotesta) of female tree seeds, which releases butyric acid and hexanoic acid. These volatile fatty acids are responsible for the odor but are not the primary allergens. The main allergens in the sarcotesta are ginkgolic acids — specifically anacardic acid derivatives — which are potent contact sensitizers structurally related to urushiol from poison ivy. Contact with the sarcotesta can trigger allergic contact dermatitis indistinguishable from a poison ivy reaction, appearing 24 to 48 hours after skin contact. The odor itself is not an allergen but serves as a useful indicator of proximity to the allergenic material.
This depends on your specific allergy mechanism. If your allergy is to ginkgo pollen (IgE-mediated, spring), ginkgo nuts as a food are generally not cross-reactive because ginkgo pollen allergens have not been characterized as food allergens and no pollen-food syndrome is documented for ginkgo. If your allergy is to ginkgolic acids from fruit sarcotesta contact, the cooking process substantially reduces but does not fully eliminate ginkgolic acid in the nuts, so raw handling should be avoided. All individuals should limit ginkgo nut consumption to small quantities per sitting due to the 4-O-methylpyridoxine content, which is unrelated to allergy and can cause neurological effects in excess — particularly in children. Discuss specific dietary risks with your allergist based on your confirmed mechanism.
They are separate allergies but may cross-react because their sensitizing chemicals are structurally similar. Ginkgolic acids — found in the fleshy outer coat of female ginkgo seeds — are anacardic acid derivatives with long alkyl chains on a phenolic ring, structurally homologous to urushiol from poison ivy (Toxicodendron radicans). Patients who are already sensitized to poison ivy may develop a more severe and rapid contact dermatitis reaction on first exposure to ginkgo seed sarcotesta because their T-cell memory can recognize the structurally similar molecule. However, not all ginkgo-sensitized patients are poison ivy-sensitized, and vice versa. Patch testing can clarify individual cross-reactivity patterns.
Yes — reactions to ginkgo biloba supplements are documented. Two mechanisms apply: first, supplements containing inadequately purified ginkgo extract may have elevated ginkgolic acid content, which can trigger allergic contact reactions in sensitized individuals — particularly mucosal reactions from oral exposure. EU regulations require ginkgolic acid below 5 ppm in supplements to minimize this risk, but product quality varies internationally and is not FDA-regulated in the US. Second, some individuals experience contact urticaria or systemic reactions that may involve other ginkgo leaf components. If you have had skin reactions to ginkgo tree seeds and are considering a ginkgo supplement, discuss this history with your physician and choose a product specifying ginkgolic acid content below 5 ppm.
The only reliable way to determine ginkgo tree sex is to observe whether the tree produces fruit (seeds with fleshy sarcotesta) in late summer and autumn. Female trees produce clusters of round to oval seeds approximately 2 to 3 centimeters in diameter enclosed in the malodorous yellow-orange fleshy coating beginning in August to September. Male trees produce no fruit and are entirely clean in autumn. Young trees are vegetatively identical and cannot be sexed until they begin reproducing — typically after 20 or more years of growth. In many US cities, municipal records or park department databases can indicate whether street-planted ginkgo trees are certified male cultivars, which are now available for urban planting specifically to avoid fruit production.
Ginkgo pollen season is brief, typically lasting 2 to 4 weeks during March and April in temperate US cities. The timing shifts slightly by region and annual temperature: in warmer urban climates and the Southern US, pollen release may begin in late February; in northern US cities or colder springs, it may extend into early May. Once male catkins have shed their pollen and the brief spring window closes, airborne ginkgo pollen drops to zero and pollen-related symptoms resolve. If spring respiratory symptoms persist after May, they are almost certainly due to other allergens — grass pollen begins its season in May through June — rather than residual ginkgo pollen.
Ginkgo contact dermatitis from ginkgolic acid exposure closely resembles poison ivy dermatitis. Within 24 to 48 hours after skin contact with the female seed sarcotesta, the affected areas develop erythema (redness), followed by papules and vesicles (fluid-filled blisters) that may weep clear fluid. Intense itching is characteristic. The distribution follows wherever skin contacted the sensitizing material — typically hands, forearms, or the face if hands touched it subsequently. Without treatment and re-exposure prevention, the rash peaks at 48 to 72 hours and gradually resolves over 1 to 3 weeks. Scratching can spread fluid and introduce secondary bacterial infection. Seek medical evaluation for extensive or rapidly spreading reactions, especially if vesicles involve the face or eyes.
Children can develop ginkgo contact allergy from playing near female ginkgo trees and handling the seeds, which can resemble small interesting fruits to curious children. The ginkgolic acid contact dermatitis would present identically to poison ivy exposure. A separate and more acute concern for children is ginkgo seed neurotoxicity: the compound 4-O-methylpyridoxine in seeds can cause vomiting and seizures when children ingest more than a small number of seeds — this is a pharmacological toxicity unrelated to allergy and constitutes a medical emergency. Parents should prevent children from handling or eating ginkgo seeds. Ginkgo pollen allergy is theoretically possible in atopic children during spring but has not been characterized in pediatric allergy literature.
Only male ginkgo trees produce pollen. Ginkgo is dioecious, meaning individual trees are either entirely male or entirely female — unlike many plants where both functions occur on the same tree. Male trees produce small catkin-like pollen structures at the base of leaves in spring. Female trees produce ovules that develop into seeds if pollinated, but produce no pollen themselves. Municipalities and landscape architects have increasingly favored male cultivars (branded cultivars like 'Autumn Gold' and 'Princeton Sentry' are male) specifically to avoid the malodorous female fruit, meaning many urban street ginkgo plantings are pollen-producing male trees — inadvertently concentrating pollen exposure in city environments.
Medical References
- [1]Lepoittevin JP, Benezra C, Asakawa Y. Allergic contact dermatitis to ginkgolic acids. Arch Dermatol Res. 1989;281(4):227–230.
- [2]Chiu AE, Lane AT, Kimball AB. Contact dermatitis caused by ginkgo fruit. Arch Dermatol. 2002;138(1):82–83.
- [3]Hausen BM. Ginkgo-biloba allergic contact dermatitis. Hautarzt. 1998;49(11):917–921.
- [4]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy. 2007;62(9):976–990.
- [5]Rodríguez R, Villalba M, Batanero E, et al. Emerging pollen allergens. Biomed Pharmacother. 2007;61(2–3):86–96.
- [6]American Academy of Allergy, Asthma & Immunology (AAAAI). Tree Pollen Allergy Overview.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Ginkgo allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
